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Regulated exocytosis: A new deadly Syn?
Geoffrey D. Holman
Insulin-mediated regulation of the exocytosis of
vesicles containing the glucose transporter GLUT4 has
similarities to regulated synaptic transmission. A recent
study has now identified a key regulated component of
the fusion step in the exocytosis of these GLUT4-
containing vesicles.
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Insulin signalling in its target cells of adipose tissue and
skeletal and cardiac muscle results in a massive stimula-
tion of the movement of the glucose transporter GLUT4
from an intracellular storage compartment to the plasma
membrane. This translocation process is critical for
insulin-induced glucose uptake, because it produces a net
increase in the number of glucose transporter molecules
available at the plasma membrane. In the basal state virtu-
ally all of the GLUT4 molecules are sequestered intracel-
lularly in a basal reservoir compartment [1]. Following
insulin stimulation, these GLUT4-containing vesicles are
rapidly exocytosed [2]. Understanding the mechanisms
controlling the rapid exocytosis of GLUT4 is important
because the pathogenesis of type 2 diabetes mellitus may
be related to failures in the translocation of GLUT4 [3,4].
A recent paper by Min et al. [5] describes a new compo-
nent of the machinery involved in translocating GLUT4-
containing vesicles termed Synip. This discovery focuses
attention on the fusion of these vesicles with the plasma
membrane as being the key regulated step in their exocy-
tosis. This step has many similarities to regulated synaptic
vesicle release and involves similar components. 
GLUT4 vesicle transport and fusion machinery
Recent studies on the subcellular transport of GLUT4
have led to the characterisation of the machinery neces-
sary for the sorting of this molecule into vesicular struc-
tures and the identification of the proteins necessary for
fusion of these vesicles with the plasma membrane.
Many of the components involved in synaptic vesicle
transport, docking and fusion are now known to also be
involved in the processing of GLUT4-containing vesi-
cles [3]. These shared components include the N-ethyl-
maleimide-sensitive fusion (NSF) protein, which interacts
with soluble NSF attachment proteins (SNAPs), and con-
sequently with SNAP receptors or SNAREs. However,
the details of the sequence of their participation and the
mechanisms by which these processes are regulated are
still being investigated. 
Target SNAREs, or t-SNAREs, serve as the docking points
for vesicles at the plasma membrane. Of the t-SNAREs,
Syntaxin4 but not Syntaxins 1a, 1b or 3 can be detected in
the plasma membrane of insulin-responsive cells, such as
adipocytes and muscle cells [6]. An additional t-SNARE
protein, SNAP23, is also present in the plasma membrane
of these tissues [7]. An important Syntaxin4-binding
protein found in insulin-responsive tissues is Munc18c [8],
a homologue of the neuronal proteins Munc18a and 18b
and the yeast protein nSec1, which are implicated in the
regulation of neuronal and yeast secretory pathways,
respectively. Vesicle SNAREs, or v-SNAREs, interact with
the t-SNAREs thereby docking the vesicle at the plasma
membrane. The v-SNAREs of the synaptobrevin family
VAMP2 (or synaptobrevin-2) and cellubrevin, but not
synaptobrevin-1, are present in GLUT4-containing vesi-
cles [6,9]. These v-SNAREs in the GLUT4 vesicles and
the t-SNAREs Syntaxin4 and SNAP23 from the plasma
membrane of adipocytes have been found to form a
complex with recombinant NSF and α-SNAP [6,10]. Fur-
thermore, insulin increases the amount of GLUT4 vesicle
VAMP2 in the NSF–α-SNAP fusion complex [6]. These
studies link Syntaxin4 with the docking reactions of the
GLUT4-containing vesicles (Figure 1).
Synip as a regulated fusion clamp
A key feature of synaptic transmission that distinguishes
this process from constitutive membrane protein transport
is the presence of ‘fusion clamps’ [11] that block vesicle
fusion by reducing the availability of v- and t-SNAREs.
The work by Min et al. [5] suggests that a fusion clamp
may also act in the regulation of GLUT4 transport
(Figure 1). Syntaxin4 was used as a bait in a yeast two-
hybrid interaction screen to identify potential Syntaxin4-
binding proteins. This screen led to the isolation of a
cDNA that encoded a protein of 61 kDa, which they
termed Synip (for Syntaxin4-interacting protein). Struc-
tural domain analysis of this protein revealed that it has an
amino-terminal PDZ domain, followed by a potential
calcium-binding EF-hand motif, two central coiled-coil
domains and a WW domain close to the carboxyl terminus. 
The distribution of Synip is particularly striking. It appears
to be present in high amounts only in insulin-responsive
tissues of skeletal muscle, heart and adipose tissue — those
tissues where GLUT4 is also expressed. This observation
is particularly important because the protein with which
Synip interacts, Syntaxin4, is ubiquitously expressed. The
restricted expression of Synip therefore provides the
cell-type specificity of this interaction. Min et al. [5] were
also able to demonstrate that insulin-treatment of cells
led to around a 70% reduction in the amount of recombi-
nant Synip bound to Syntaxin4. So, as with the fusion
clamps in synaptic transmission, Synip seems to hold
Syntaxin4 in an inactive state, preventing it from inter-
acting with v-SNAREs.
Synip does not affect the interaction between Syntaxin4
and SNAP23, but it does reduce the interaction between
Syntaxin4 and VAMP2. This feature led the authors to
suggest a model for insulin action (Figure 1) in which the
VAMP2 on GLUT4-containing vesicles can only dock
with plasma membrane Syntaxin4 when Synip is released.
In support of this hypothesis, they demonstrated that a
carboxy-terminal portion of Synip can block insulin-stimu-
lated glucose transport by around 50%. An amino-terminal
region of Synip could not block insulin-stimulated trans-
port, however. The implication is that signalling mole-
cules interact with the amino-terminal section of Synip,
possibly through the PDZ domain in this region, and this
alters the conformation in the carboxy-terminal section
and thereby weakens the interaction with Syntaxin4.
The link to insulin signalling
Studies on the mechanism by which insulin signalling
leads to reduced interaction between Synip and Syntaxin4
are now likely to emerge rapidly. These studies will prob-
ably focus on the potential phosphorylation of Synip and
related molecules. Syntaxin4 is known to be a substrate
for protein kinase A and casein kinase II [12] whereas the
Munc18 proteins are substrates for protein kinase C
(PKC) [13]. Binding of Synip to Syntaxin4 or the Munc18
proteins may modify the accessibility of these phosphory-
lation sites. Another potential mechanism for insulin regu-
lation may involve the amino-terminal PDZ domain of
Synip. PDZ domains are known to be involved in generat-
ing protein scaffolds that include signalling intermediates
such as protein tyrosine phosphatases and cytoskeleton-
binding proteins. Again, parallels with synaptic transmis-
sion are evident — PDZ-domain-containing proteins at
pre-synaptic membranes produce a scaffold of proteins in
an ‘active zone’ of neurotransmitter release [14,15]. An
active zone and protein scaffold for regulated docking and
fusion may therefore also be present in insulin-responsive
tissues, in which case Synip and its binding partners
would be key components of such a zone.
Studies on the GLUT4 docking and fusion mechanism
and the scaffolding around this zone of fusion activity will
ultimately lead back to the now well-characterised steps
in early insulin signalling. These include the tyrosine
kinase activity of the insulin receptor and its activation of
phosphatidylinositol (PI) 3-kinase (Figure 2; for a review,
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Figure 1
Docking and fusion of GLUT4-containing vesicles at the plasma
membrane are dependent on interactions between v- and t-SNAREs
and the activity of fusion clamps. It is postulated by Min et al. [5] that,
following insulin signalling, Synip binding to Syntaxin4 is reduced. This
process may be dependent on a PDZ-binding protein that interacts
with the amino-terminal region of Synip and alters the conformation of
its carboxy-terminal Syntaxin4-binding domain. This releases Syntaxin4
which can then interact with an additional t-SNARE (SNAP23) and the
GLUT4 v-SNARE (VAMP2). Munc18c at the plasma membrane and a
20 kDa G protein of the Rab family on GLUT4 vesicles may also
participate in the regulation of the vesicle fusion.
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Figure 2
Insulin-mediated regulation of the exocytosis of GLUT4-containing
vesicles involves the insulin-receptor-stimulated tyrosine
phosphorylation (shown as green dots) of adaptor molecules of the
insulin receptor substrate (IRS) family that then couple to PI 3-kinase.
The lipid products of PI 3-kinase activity (PIPs) then activate or localise
the activities of downstream PIP-binding proteins. It has been
postulated that PKB and atypical PKCs are downstream mediators of
insulin action on GLUT4 translocation although other PIP-binding
proteins may also participate.
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see [16]). PI 3-kinase isoforms produce several PI lipids
including PI 3,4,5-trisphosphate (PIP3), the 3,4 and 3,5 PI
bisphosphates and the monophosphate PI 3-phosphate.
Microinjection of an active form of the inositol 5′-phos-
phatase SHIP reduces cellular PIP3 levels and GLUT4
translocation. This finding implies that PIP3 may be the
intermediate involved in interactions with downstream
molecules in insulin signalling [17], although the involve-
ment of the other lipid products of PI 3-kinase has not
been ruled out. Downstream molecules that interact with
the inositol lipid products of PI 3-kinase include the
serine kinase protein kinase B and the atypical PKC iso-
forms. Studies using constitutively active and dominant-
negative forms of these enzymes have implicated their
action in the regulation of GLUT4 translocation [18–21].
Now that an insulin-regulated fusion process for GLUT4-
containing vesicles has been identified, it should be possi-
ble to focus on the subset of PIP3-binding proteins and/or
PIP3-regulated enzymes that impinge upon this step.
Finally, the drive towards further resolution of the mech-
anisms involved in insulin regulation of GLUT4 subcel-
lular transport will lead to a greater understanding of the
defect(s) in these processes that are responsible for type
II diabetes. Will defective forms of Synip, Munc18c or
one of their binding partners turn out to be a deadly
pathogenic component?
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